Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Return on Sales (2016 - 2025)

Historic Return on Sales for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 0.0%.

  • AtriCure's Return on Sales rose 700.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.1% for FY2024, which is 200.0% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Return on Sales is 0.0%, which was up 700.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, AtriCure's Return on Sales ranged from a high of 1.38% in Q3 2021 and a low of 0.29% during Q1 2021
  • Moreover, its 5-year median value for Return on Sales was 0.09% (2023), whereas its average is 0.04%.
  • As far as peak fluctuations go, AtriCure's Return on Sales soared by 14700bps in 2021, and later crashed by -15300bps in 2022.
  • Quarter analysis of 5 years shows AtriCure's Return on Sales stood at 0.19% in 2021, then soared by 75bps to 0.05% in 2022, then tumbled by -94bps to 0.09% in 2023, then plummeted by -36bps to 0.13% in 2024, then surged by 98bps to 0.0% in 2025.
  • Its Return on Sales stands at 0.0% for Q3 2025, versus 0.05% for Q2 2025 and 0.05% for Q1 2025.